|
|||||
|
|
A Novel PRKAR1A::MET Fusion Dramatic Response to Crizotinib in a Patient with Unresectable Lung Cancer |
|
| Affiliation: | 1. Department of Respiratory Diseases, Harbin Medical University Cancer Hospital, Heilongjiang Province, Harbin, China;2. Department of Translational Medicine, Genetron Health (Beijing) Co. Ltd., Beijing, China |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |